Anticavity Rinse

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children 6 years of age and older are instructed to use the rinse once daily, following the brushing of their teeth with toothpaste. The recommended method involves vigorously swishing 10 milliliters of the rinse between the teeth for a duration of 1 minute, after which the solution should be expectorated. It is imperative that the rinse is not swallowed. Additionally, patients should refrain from eating or drinking for 30 minutes following the rinsing procedure to ensure optimal efficacy.

For children under 12 years of age, it is essential to instruct them in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be required until the child demonstrates the ability to use the rinse without assistance. For children under 6 years of age, consultation with a dentist or physician is recommended prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if more than the recommended amount used for rinsing is accidentally swallowed, professional assistance should be sought or a Poison Control Center contacted immediately.

Warnings and Precautions

If more than the recommended amount for rinsing is accidentally ingested, it is imperative to seek professional assistance or contact a Poison Control Center immediately. Healthcare professionals should be vigilant in advising patients about the importance of adhering to the prescribed usage to prevent potential adverse effects associated with overconsumption.

In the event of any unexpected reactions or concerns regarding the product, healthcare providers are encouraged to maintain open lines of communication with their patients, ensuring that they understand when to seek further medical evaluation.

Side Effects

There are no specific adverse reactions or warnings associated with the use of this product. Clinical trials and postmarketing experiences have not identified any notable adverse reactions. As such, healthcare professionals should continue to monitor patients for any unexpected effects during treatment, although no documented adverse reactions have been reported to date.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Anticavity Rinse (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be instructed to keep the product out of reach of children. In the event that more than the recommended amount for rinsing is accidentally swallowed, it is essential to seek professional assistance or contact a Poison Control Center immediately.

For adults and children aged 6 years and older, the recommended usage is once daily after brushing teeth with toothpaste. Patients should vigorously swish 10 milliliters of the rinse between their teeth for 1 minute and then spit it out, ensuring that the rinse is not swallowed. It is advised not to eat or drink for 30 minutes following the rinse.

Children under 12 years of age should be instructed in proper rinsing techniques to minimize the risk of swallowing the rinse, and supervision is recommended until they are capable of using the product without assistance. For children under 6 years of age, consultation with a dentist or doctor is advised prior to use.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The use of this medication during pregnancy has not been specifically addressed in the available prescribing information. There are no documented safety concerns related to pregnancy, and no dosage modifications for pregnant individuals are recommended. Additionally, the prescribing information does not outline any special precautions for the use of this medication in pregnant patients. Healthcare professionals should consider the absence of specific data when prescribing this medication to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced renal function. It is essential for these patients to have their renal function monitored regularly to ensure safe and effective use of the medication. Dosage adjustments should be based on creatinine clearance levels, with particular attention given to patients with severe renal impairment, who may require special consideration in their treatment regimen.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient's characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment and Monitoring: Conduct a thorough evaluation of the patient's vital signs, mental status, and any presenting symptoms. Continuous monitoring may be necessary to detect any deterioration in the patient's condition.

2. Supportive Care: Initiate supportive measures as needed, which may include airway management, oxygen supplementation, intravenous fluids, and medications to stabilize cardiovascular function.

3. Decontamination: If the overdose is recent and the patient is alert and able to protect their airway, consider activated charcoal administration to limit further absorption of the substance. Gastric lavage may be indicated in certain cases, but only if performed within a suitable timeframe and under appropriate clinical circumstances.

4. Specific Antidotes: If applicable, identify and administer any specific antidotes that may be available for the substance involved in the overdose.

5. Consultation: Engage with a poison control center or toxicology expert for guidance on management strategies tailored to the specific substance and clinical scenario.

6. Documentation: Ensure thorough documentation of the incident, including the substance involved, estimated dose, time of ingestion, and all interventions performed.

In summary, while no specific overdosage information is provided, healthcare professionals should be prepared to act swiftly and effectively in managing potential overdose situations, utilizing established protocols and resources to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients that if more than the recommended amount used for rinsing is accidentally swallowed, it is crucial to seek professional assistance or contact a Poison Control Center immediately. This information is essential for ensuring patient safety and prompt action in case of accidental ingestion.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are necessary beyond standard storage practices.

Additional Clinical Information

Patients should administer the rinse orally once a day after brushing their teeth. The recommended method involves vigorously swishing 10 milliliters of the rinse between the teeth for 1 minute before spitting it out. It is important that patients do not swallow the rinse and refrain from eating or drinking for 30 minutes following the rinse.

Clinicians should advise that children under 12 years of age be instructed in proper rinsing techniques to minimize the risk of swallowing the rinse. Supervision may be necessary until the child is capable of using the rinse independently.

Drug Information (PDF)

This file contains official product information for Anticavity Rinse, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)